Watch NIH Clinical Center front-line healthcare workers and HHS and NIH leadership receive the COVID-19 vaccine.
Fifth Phase 3 clinical trial for a COVID-19 vaccine begins enrolling volunteers.
Co-developed with NIH, mRNA-1273 vaccine demonstrates 94% efficacy.
Join the fight against COVID-19 by participating in a late phase clinical trial or donating plasma.